Translational Development Acquisition Corp. Ordinary Shares (TDAC)
TurnaroundFairStock Score: 41/100 — MIXED
Key Financials
| Current Price | $10.81 |
| Market Cap | $234M |
| P/E Ratio | 41.58 |
| ROE | —% |
| Dividend Yield | 0% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look first for a business with durable earnings, a moat, and honest financials. Translational Development Acquisition Corp. offers none of those today: it is a shell with no significant operations, no revenue in the filed figures, and its stated purpose is to acquire or merge with an unidentified business. The reported profits are therefore not operating profits. In fiscal 2025, the company reported net income of $6.4M, a reversal from a net loss of $71,012 in fiscal 2024, and a net loss of $485,550 in fiscal 2023. In fiscal Q2 2026, the quarter ended 2026-06-30, it reported net income of $946,982, and in fiscal Q1 2026, the quarter ended 2026-03-31, net income was $1.3M. Yet trailing free cash flow is negative $849,378, and the Piotroski F-Score is only 1/9, which is a weak set of signals. FairStock labels it a TURNAROUND because it returned to profit after a loss within the last three years, but a SPAC's reported income can be an accounting artifact rather than evidence of business quality. At the 2026-10-13 close of $10.83, FairStock's P/E is 41.65, while its Graham Number is $6.73, implying a margin of safety of negative 60.92%. The Altman Z-Score of 17.96 is high, but for a shell that is less meaningful than for an operating company. Without a target, there is no moat, no growth engine, and no way to value the enterprise on earnings power. I would wait for a real business with real revenue before judging the price.
In plain English: Translational Development Acquisition Corp. is a shell company with no real operations; it was set up to merge with or buy another business. Its filed results show no revenue and small positive net income in recent periods, but cash flow is negative, so the operating business is not yet proven. At $10.83, the shares look expensive against the limited numbers it reports, although the real value will depend on whatever deal it eventually makes.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer